Results 161 to 170 of about 29,923 (224)
CT-Guided Preoperative Localization With Coil Placement for Surgical Resection of a Phosphaturic Mesenchymal Tumor: A Case Report and Review of the Literature. [PDF]
CureusArroyave Peña T +6 more
europepmc +1 more source
Somatostatin receptors 3 and 5 potentiate cholinergic-nerve-mediated contraction in human bronchus. [PDF]
Front PharmacolBrollo M +7 more
europepmc +1 more source
Spinal decompression and radionuclide therapy for an unresectable FGF23 transmitted tumor causing cervical myelopathy: a case report and literature review. [PDF]
Front OncolYokoyama S +10 more
europepmc +1 more source
Editorial: Case reports in PET imaging 2024. [PDF]
Front Med (Lausanne)Caldarella C +2 more
europepmc +1 more source
Multimodal strategies for diagnosing and treating thyroid cancer: Advances in basic and clinical research. [PDF]
Transl OncolZhao Y +5 more
europepmc +1 more source
Advances in the Treatment of Autosomal Dominant Polycystic Kidney Disease and Novel Therapeutic Targets. [PDF]
Curr Issues Mol BiolZhang W, Sun T, Wang X, Jiang T.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Trends in Endocrinology and Metabolism, 1985
It is now well established that the biological actions of tetradecapeptide somatostatin (somatostatin-14, S-14) are receptor-mediated. These receptors were first quantified in GH4C pituitary tumor cells using [125I-Tyr1] S-14 as radioligand which was found to exhibit high non-specific binding to membrane receptor preparations from normal tissues.
Y C, Patel, C B, Srikant
openaire +4 more sources
It is now well established that the biological actions of tetradecapeptide somatostatin (somatostatin-14, S-14) are receptor-mediated. These receptors were first quantified in GH4C pituitary tumor cells using [125I-Tyr1] S-14 as radioligand which was found to exhibit high non-specific binding to membrane receptor preparations from normal tissues.
Y C, Patel, C B, Srikant
openaire +4 more sources
American Journal of Physiology-Gastrointestinal and Liver Physiology, 1995
Somatostatin induces its biological actions by activating a family of receptor subtypes. The recent cloning of five somatostatin receptor subtypes has led to the development of subtype-selective agonists. These compounds are revealing distinct functions of the individual receptor subtypes.
R. A. James, D. R. Weightman
openaire +3 more sources
Somatostatin induces its biological actions by activating a family of receptor subtypes. The recent cloning of five somatostatin receptor subtypes has led to the development of subtype-selective agonists. These compounds are revealing distinct functions of the individual receptor subtypes.
R. A. James, D. R. Weightman
openaire +3 more sources